Literature DB >> 35845114

microRNA-26b inhibits growth and cellular invasion of ovarian cancer cells by targeting estrogen receptor α.

Guna He1, Xiaomei Liu1, Lingyu Liu1.   

Abstract

The current study set out to elucidate the mechanism of miR-26b in OC cell proliferation and EMT via suppression of ERα. Initial findings illustrated that miR-26b was poorly expressed in OC tissues and cells. On the other hand, over-expression of miR-26b exerted a diminishing effect on SKOV3 cell proliferation, migration, invasion and EMT, whereas silencing of miR-26b conferred an enhancing effect on CAOV3 cell proliferation, migration, invasion and EMT. Subsequently, with help from the TargetScan database, a dual-luciferase reporter gene assay was carried out to verify the targeting relation between miR-26b and ERα, which revealed that miR-26b could negatively modulate ERα. Furthermore, the in vivo experimentation illustrated that over-expression of miR-26b led to down-regulation of ERα and suppression OC tumor growth and EMT. Meanwhile, silencing of ERα inhibited OC cell proliferation, migration, invasion and EMT. In conclusion, our findings indicated that miR-26b inhibited OC cell proliferation and EMT via negative-modulation of ERα. This investigation may offer potential strategy for OC treatment. Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-022-03222-2. © King Abdulaziz City for Science and Technology 2022.

Entities:  

Keywords:  Cell cycle; Epithelial-mesenchymal transition; Estrogen receptor α; Invasion; MicroRNA-26b; Migration; Ovarian cancer; Proliferation

Year:  2022        PMID: 35845114      PMCID: PMC9276861          DOI: 10.1007/s13205-022-03222-2

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.893


  41 in total

Review 1.  Epidemiology of epithelial ovarian cancer.

Authors:  Penelope M Webb; Susan J Jordan
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2016-10-03       Impact factor: 5.237

Review 2.  Ovarian cancer in the older woman.

Authors:  William P Tew
Journal:  J Geriatr Oncol       Date:  2016-08-05       Impact factor: 3.599

3.  Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer.

Authors:  Qingqing Ding; Yan Wang; Zhuang Zuo; Yun Gong; Savitri Krishnamurthy; Chia-Wei Li; Yun-Ju Lai; Wei Wei; Jing Wang; Ganiraju C Manyam; Lixia Diao; Xinna Zhang; Feng Lin; William F Symmans; Li Sun; Chang-Gong Liu; Xiuping Liu; Bisrat G Debeb; Naoto T Ueno; Kenichi Harano; Ricardo H Alvarez; Yun Wu; Massimo Cristofanilli; Lei Huo
Journal:  Hum Pathol       Date:  2018-04-22       Impact factor: 3.466

Review 4.  [Ovarian cancer--from biology to clinic].

Authors:  Katarzyna Aleksandra Kujawa; Katarzyna Marta Lisowska
Journal:  Postepy Hig Med Dosw (Online)       Date:  2015-12-02       Impact factor: 0.270

5.  MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.

Authors:  Jiaxin Lin; Lan Zhang; He Huang; Yongwen Huang; Long Huang; Jianhua Wang; Shuting Huang; Li He; Yun Zhou; Weihua Jia; Jingping Yun; Rongzhen Luo; Min Zheng
Journal:  Oncotarget       Date:  2015-09-15

6.  Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.

Authors:  Yang Li; Zheng Sun; Bing Liu; Yujia Shan; Lifen Zhao; Li Jia
Journal:  Cell Death Dis       Date:  2017-06-22       Impact factor: 8.469

7.  MicroRNA-26b acts as an antioncogene and prognostic factor in cervical cancer.

Authors:  Lihong Wang; Wen Wang; Yuanyuan Wu
Journal:  Oncol Lett       Date:  2019-01-24       Impact factor: 2.967

8.  Long Noncoding RNA PVT1 Promotes Melanoma Progression via Endogenous Sponging miR-26b.

Authors:  Bao-Juan Wang; Hong-Wei Ding; Guo-An Ma
Journal:  Oncol Res       Date:  2017-04-12       Impact factor: 5.574

Review 9.  The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer.

Authors:  Goda G Muralidhar; Maria V Barbolina
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

10.  MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells.

Authors:  Ying Chen; Dan-Dan Wang; Ye-Ping Wu; Dan Su; Tian-Yi Zhou; Ren-Hua Gai; Ying-Ying Fu; Lin Zheng; Qiao-Jun He; Hong Zhu; Bo Yang
Journal:  Br J Cancer       Date:  2017-08-17       Impact factor: 9.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.